Document is current
Any future updates will be listed below
-
Authors
Tatekawa, Hiroyuki
Hagiwara, Akifumi
Uetani, Hiroyuki
Bahri, Shadfar
Raymond, Catalina
Lai, Albert
Cloughesy, Timothy F.
Nghiemphu, Phioanh L.
Liau, Linda M.
Pope, Whitney B.
Salamon, Noriko
Ellingson, Benjamin M. https://orcid.org/0000-0002-2764-6640
-
Funding
Funding for this research was provided by:
Society of Nuclear Medicine and Molecular Imaging
American Cancer Society (RSG-15-003-01-CCE)
American Brain Tumor Association (ARC1700002)
National Brain Tumor Society
NIH/NCI UCLA Brain Tumor SPORE (1P50CA211015-01A1, 1P50CA211015-01A1, 1P50CA211015-01A1, 1P50CA211015-01A1)
NIH/NCI (1R21CA223757-01)
- License Information
-
More Information
Article History
Received: 18 November 2020
Accepted: 2 March 2021
First Online: 10 March 2021
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all individual participants to have their imaging, clinical, and molecular data included in our research database (IRB IRB#10–000655).
: Not applicable.
: Ellingson—Advisory Board— Hoffman La-Roche; Siemens; Nativis; Medicenna; MedQIA; Bristol-Myers Squibb; Imaging Endpoints; Agios. Paid Consultant—Nativis; MedQIA; Siemens; Hoffman La-Roche; Imaging Endpoints; Medicenna; Agios. Grant Funding—Hoffman La-Roche; Siemens; Agios; Janssen. Ellingson also holds a patent on this technology (US Patent #15/577,664; International PCT/US2016/034886). Cloughesy—Advisory Board—Roche/ Genentech, Amgen, Tocagen, NewGen, LPath, Proximagen, Celgene, Vascular Biogenics Ltd., Insys, Agios, Cortice Bioscience, Pfizer, Human Longevity, BMS, Merck, Notable Lab, MedQIA.
